Lymph Node Density Predicts Thyroid Cancer Outcomes
Papillary thyroid cancer patients with LND >0.19 have worse disease-specific, overall survival
Nivolumab May Induce Successful Depletion of HIV Reservoir
Case report describes smoker with HIV infection receiving nivolumab for non-small-cell lung cancer
Oral Microbiome Composition Linked to Esophageal Cancer Risk
Periodontal pathogen Tannerella forsythia linked to increased risk of esophageal adenocarcinoma
Ceruloplasmin ID’d As Marker of Kidney Disease in Sickle Cell
Findings part of proteomic analysis of urine in patients with sickle cell disease
November 2017 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for November 2017. This roundup includes...
>40% of Cancers, Cancer Deaths Due to Modifiable Risk Factors
Cigarette smoking accounts for highest proportion of cancer cases (19.0 percent), deaths (28.8 percent)
Lobectomy Beats SBRT Survival in Early-Stage NSCLC
Higher cancer mortality for SBRT versus lobectomy; no difference for SBRT, sublobar resection
Differences in Cancer Survival by Type of Insurance
Survival up in patients with private insurance, Medicare; no change or drop with other, no insurance
ACC Guides Treatment of Bleeding With Oral Anticoagulation
Pathway supports clinician decision making during management of patients with bleeding complications
Study IDs Clinical Factors Tied to Free Tissue Transfer Reoperation
Findings among patients undergoing free tissue transfer for head, neck cancer-related defects
